ST14 Antikörper (AA 566-855)
Kurzübersicht für ST14 Antikörper (AA 566-855) (ABIN7171018)
Target
Alle ST14 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 566-855
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Antigen Affinity purified
-
Immunogen
- Recombinant Human Suppressor of tumorigenicity 14 protein (566-855AA)
-
Isotyp
- IgG
-
-
anti-Suppression of Tumorigenicity 14 (ST14) (AA 11-100) antibody
ST14 Reaktivität: Human WB, ELISA, IHC (p), IF (cc), IF (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 607-852) antibodyST14 Reaktivität: Human WB, IHC Wirt: Maus Monoclonal C4 unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 826-855), (C-Term) antibodyST14 Reaktivität: Human, Maus WB, IHC (p) Wirt: Kaninchen Polyclonal RB2080 unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (Internal Region) antibodyST14 Reaktivität: Human, Maus WB, IHC, ELISA, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) antibodyST14 Reaktivität: Human, Maus, Ratte WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (C-Term) antibodyST14 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Hund, Schwein, Kaninchen WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (N-Term) antibodyST14 Reaktivität: Human WB, IF, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) antibodyST14 Reaktivität: Human, Maus IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 298-400) antibodyST14 Reaktivität: Human ELISA Wirt: Maus Monoclonal 2F4 unconjugated
anti-Suppression of Tumorigenicity 14 (ST14) (AA 10-59) antibodyST14 Reaktivität: Human WB, IHC, ELISA, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- ST14 (Suppression of Tumorigenicity 14 (ST14))
-
Andere Bezeichnung
- ST14
-
Hintergrund
-
Background: Degrades extracellular matrix. Proposed to play a role in breast cancer invasion and metastasis. Exhibits trypsin-like activity as defined by cleavage of synthetic substrates with Arg or Lys as the P1 site. Involved in the terminal differentiation of keratinocytes through prostasin (PRSS8) activation and filaggrin (FLG) processing.
Aliases: Epithin antibody, HAI antibody, Matriptase antibody, Membrane type serine protease 1 antibody, Membrane type serine protease antibody, Membrane-type serine protease 1 antibody, MT SP1 antibody, MT-SP1 antibody, MTSP 1 antibody, MTSP1 antibody, Prostamin antibody, PRSS 14 antibody, PRSS14 antibody, Serine protease 14 antibody, Serine protease TADG 15 antibody, Serine protease TADG-15 antibody, Serine protease TADG15 antibody, SNC 19 antibody, SNC19 antibody, ST 14 antibody, ST14 antibody, ST14_HUMAN antibody, Suppression of tumorigenicity 14 (colon carcinoma matriptase epithin) antibody, Suppression of tumorigenicity 14 (colon carcinoma) antibody, Suppression of tumorigenicity 14 antibody, Suppressor of tumorigenicity 14 protein antibody, Suppressor of tumorigenicity protein 14 antibody, TADG 15 antibody, TADG15 antibody, TMPRSS14 antibody, Tumor associated differentially expressed gene 15 protein antibody, Tumor-associated differentially-expressed gene 15 protein antibody
-
UniProt
- Q9Y5Y6
Target
-
